Gastric cancer-derived exosomes promote peritoneal metastasis by destroying the mesothelial barrier

FEBS Letters

Volumn 591, Issue 14, 2017, Pages 2167-2179

  Deng, Guang ^a   Qu, Jinglei ^a   Zhang, Ye ^a   Che, Xiaofang ^a   Cheng, Yu ^a   Fan, Yibo ^a   Zhang, Simeng ^a   Na, Di ^a   Liu, Yunpeng ^a   Qu, Xiujuan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

exosome; gastric cancer; mesothelial barrier destruction; peritoneal mesothelial cell; peritoneal metastasis

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; CELL DAMAGE; CELL MEMBRANE; CELL TRANSFORMATION; CONTROLLED STUDY; EXOSOME; GASTRIC CANCER CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LETTER; MALE; MESOTHELIUM CELL; MOUSE; NONHUMAN; PERITONEAL FIBROSIS; PERITONEUM METASTASIS; PERMEABILITY BARRIER; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; UPREGULATION; EPITHELIUM; MAPK SIGNALING; MESODERM; PATHOLOGY; PERITONEUM TUMOR; SECONDARY; STOMACH TUMOR; TUMOR CELL LINE;

APOPTOSIS; CELL LINE, TUMOR; EPITHELIUM; EXOSOMES; HUMANS; MAP KINASE SIGNALING SYSTEM; MESODERM; PERITONEAL NEOPLASMS; STOMACH NEOPLASMS;

EID: 85022319676     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1002/1873-3468.12722     Document Type: Article

References (52)

1. Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ and He J (2016) Cancer statistics in China, 2015. CA Cancer J Clin 66, 115–132.
2. Mutsaers SE and Wilkosz S (2007) Structure and function of mesothelial cells. Cancer Treat Res 134, 1–19.
3. Buck RC (1973) Walker 256 tumor implantation in normal and injured peritoneum studied by electron microscopy, scanning electron microscopy, and autoradiography. Cancer Res 33, 3181–3188.
4. Kiyasu Y, Kaneshima S and Koga S (1981) Morphogenesis of peritoneal metastasis in human gastric cancer. Cancer Res 41, 1236–1239.
5. Yonemura Y, Endo Y, Yamaguchi T, Fujimura T, Obata T, Kawamura T, Nojima N, Miyazaki I and Sasaki T (1996) Mechanisms of the formation of the peritoneal dissemination in gastric cancer. Int J Oncol 8, 795–802.
6. Mochizuki Y, Nakanishi H, Kodera Y, Ito S, Yamamura Y, Kato T, Hibi K, Akiyama S, Nakao A and Tatematsu M (2004) TNF-alpha promotes progression of peritoneal metastasis as demonstrated using a green fluorescence protein (GFP)-tagged human gastric cancer cell line. Clin Exp Metastasis 21, 39–47.
7. Tobioka H, Sawada N, Zhong Y and Mori M (1996) Enhanced paracellular barrier function of rat mesothelial cells partially protects against cancer cell penetration. Br J Cancer 74, 439–445.
8. Hashimoto S, Takeoka M and Taniguchi S (2003) Suppression of peritoneal dissemination through protecting mesothelial cells from retraction by cancer cells. Int J Cancer 107, 557–563.
9. Yashiro M, Chung YS, Inoue T, Nishimura S, Matsuoka T, Fujihara T and Sowa M (1996) Hepatocyte growth factor (HGF) produced by peritoneal fibroblasts may affect mesothelial cell morphology and promote peritoneal dissemination. Int J Cancer 67, 289–293.
10. Yonemura Y, Endou Y, Nojima M, Kawamura T, Fujita H, Kaji M, Ajisaka H, Bandou E, Sasaki T, amaguchi T et al. (1997) A possible role of cytokines in the formation of peritoneal dissemination. Int J Oncol 11, 349–358.
11. Nishimura S, Hirakawa-Chung KY, Yashiro M, Inoue T, Matsuoka T, Fujihara T, Murahashi K, Sawada T, Nakata B, Jikihara I et al. (1998) TGF-beta1 produced by gastric cancer cells affects mesothelial cell morphology in peritoneal dissemination. Int J Oncol 12, 847–851.
12. Stadlmann S, Raffeiner R, Amberger A, Margreiter R, Zeimet AG, Abendstein B, Moser PL, Mikuz G, Klosterhalfen B and Offner FA (2003) Disruption of the integrity of human peritoneal mesothelium by interleukin-1beta and tumor necrosis factor-alpha. Virchows Arch 443, 678–685.
13. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ and Lotvall JO (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9, 654–659.
14. Becker A, Thakur BK, Weiss JM, Kim HS, Peinado H and Lyden D (2016) Extracellular vesicles in cancer: cell-to-cell mediators of metastasis. Cancer Cell 30, 836–848.
15. Grange C, Tapparo M, Collino F, Vitillo L, Damasco C, Deregibus MC, Tetta C, Bussolati B and Camussi G (2011) Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. Cancer Res 71, 5346–5356.
16. Hood JL, San RS and Wickline SA (2011) Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. Cancer Res 71, 3792–3801.
17. Costa-Silva B, Aiello NM, Ocean AJ, Singh S, Zhang H, Thakur BK, Becker A, Hoshino A, Mark MT, Molina H et al. (2015) Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol 17, 816–826.
18. Fong MY, Zhou W, Liu L, Alontaga AY, Chandra M, Ashby J, Chow A, O'Connor ST, Li S, Chin AR et al. (2015) Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis. Nat Cell Biol 17, 183–194.
19. Hoshino A, Costa-Silva B, Shen TL, Rodrigues G, Hashimoto A, Tesic Mark M, Molina H, Kohsaka S, Di Giannatale A, Ceder S et al. (2015) Tumour exosome integrins determine organotropic metastasis. Nature 527, 329–335.
20. Heath RM, Jayne DG, O'Leary R, Morrison EE and Guillou PJ (2004) Tumour-induced apoptosis in human mesothelial cells: a mechanism of peritoneal invasion by Fas Ligand/Fas interaction. Br J Cancer 90, 1437–1442.
21. Lv ZD, Yang ZC, Wang HB, Li JG, Kong B, Wang XG, Liu XY, Niu ZH, Wang Y and Nie G (2012) The cytotoxic effect of TGF-beta1 on mesothelial cells via apoptosis in early peritoneal carcinomatosis. Oncol Rep 27, 1753–1758.
22. Na D, Song Y, Jiang CG, Sun Z, Xu YY, Wang ZN, Zhao ZZ and Xu HM (2014) Induction of apoptosis in human peritoneal mesothelial cells by gastric cancer cell supernatant promotes peritoneal carcinomatosis. Tumour Biol 35, 8301–8307.
23. Aroeira LS, Aguilera A, Sanchez-Tomero JA, Bajo MA, del Peso G, Jimenez-Heffernan JA, Selgas R and Lopez-Cabrera M (2007) Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions. J Am Soc Nephrol 18, 2004–2013.
24. Tennakoon AH, Izawa T, Kuwamura M and Yamate J (2016) Pathogenesis of type 2 epithelial to mesenchymal transition (EMT) in renal and hepatic fibrosis. J Clin Med 5, 4.
25. Loureiro J, Aguilera A, Selgas R, Sandoval P, Albar-Vizcaino P, Perez-Lozano ML, Ruiz-Carpio V, Majano PL, Lamas S, Rodriguez-Pascual F et al. (2011) Blocking TGF-beta1 protects the peritoneal membrane from dialysate-induced damage. J Am Soc Nephrol 22, 1682–1695.
26. Sandoval P, Jimenez-Heffernan JA, Rynne-Vidal A, Perez-Lozano ML, Gilsanz A, Ruiz-Carpio V, Reyes R, Garcia-Bordas J, Stamatakis K, Dotor J et al. (2013) Carcinoma-associated fibroblasts derive from mesothelial cells via mesothelial-to-mesenchymal transition in peritoneal metastasis. J Pathol 231, 517–531.
27. Nakamura K, Sawada K, Kinose Y, Yoshimura A, Toda A, Nakatsuka E, Hashimoto K, Mabuchi S, Morishige KI, Kurachi H et al. (2017) Exosomes promote ovarian cancer cell invasion through transfer of CD44 to peritoneal mesothelial cells. Mol Cancer Res 15, 78–92.
28. Wei M, Yang T, Chen X, Wu Y, Deng X, He W, Yang J and Wang Z (2017) Malignant ascites-derived exosomes promote proliferation and induce carcinoma-associated fibroblasts transition in peritoneal mesothelial cells. Oncotarget, https://doi.org/10.18632/oncotarget.15040.
29. Rougier JP, Moullier P, Piedagnel R and Ronco PM (1997) Hyperosmolality suppresses but TGF beta 1 increases MMP9 in human peritoneal mesothelial cells. Kidney Int 51, 337–347.
30. Zhang L, Zhang S, Yao J, Lowery FJ, Zhang Q, Huang WC, Li P, Li M, Wang X, Zhang C et al. (2015) Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth. Nature 527, 100–104.
31. Kogure T, Lin WL, Yan IK, Braconi C and Patel T (2011) Intercellular nanovesicle-mediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth. Hepatology 54, 1237–1248.
32. Qu JL, Qu XJ, Qu JL, Qu XJ, Zhao MF, Teng YE, Zhang Y, Hou KZ, Jiang YH, Yang XH et al. (2009) The role of cbl family of ubiquitin ligases in gastric cancer exosome-induced apoptosis of Jurkat T cells. Acta Oncol 48, 1173–1180.
33. Mathivanan S, Fahner CJ, Reid GE and Simpson RJ (2012) ExoCarta 2012: database of exosomal proteins, RNA and lipids. Nucleic Acids Res 40, D1241–D1244.
34. Abusamra AJ, Zhong Z, Zheng X, Li M, Ichim TE, Chin JL and Min WP (2005) Tumor exosomes expressing fas ligand mediate CD8+ T-cell apoptosis. Blood Cells Mol Dis 35, 169–173.
35. Yokoi A, Yoshioka Y, Yamamoto Y, Ishikawa M, Ikeda SI, Kato T, Kiyono T, Takeshita F, Kajiyama H, Kikkawa F et al. (2017) Malignant extracellular vesicles carrying MMP1 mRNA facilitate peritoneal dissemination in ovarian cancer. Nat Commun 8, 14470.
36. Zhao H, Dong Y, Tian X, Tan TK, Liu Z, Zhao Y, Zhang Y, Harris D and Zheng G (2013) Matrix metalloproteinases contribute to kidney fibrosis in chronic kidney diseases. World J Nephrol 2, 84–89.
37. Radisky ES and Radisky DC (2010) Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer. J Mammary Gland Biol Neoplasia 15, 201–212.
38. Paget S (1989) The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev 8, 98–101.
39. Zhou W, Fong MY, Min Y, Somlo G, Liu L, Palomares MR, Yu Y, Chow A, O'Connor ST, Chin AR et al. (2014) Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell 25, 501–515.
40. Yashiro M, Chung YS, Nishimura S, Inoue T and Sowa M (1996) Fibrosis in the peritoneum induced by scirrhous gastric cancer cells may act as “soil” for peritoneal dissemination. Cancer 77, 1668–1675.
41. Na D, Lv ZD, Liu FN, Xu Y, Jiang CG, Sun Z, Miao ZF, Li F and Xu HM (2012) Gastric cancer cell supernatant causes apoptosis and fibrosis in the peritoneal tissues and results in an environment favorable to peritoneal metastases, in vitro and in vivo. BMC Gastroenterol 12, 34.
42. Rynne-Vidal A, Jimenez-Heffernan JA, Fernandez-Chacon C, Lopez-Cabrera M and Sandoval P (2015) The Mesothelial origin of carcinoma associated-fibroblasts in peritoneal metastasis. Cancers (Basel) 7, 1994–2011.
43. Yang Y, Pan X, Lei W, Wang J, Shi J, Li F and Song J (2006) Regulation of transforming growth factor-beta 1-induced apoptosis and epithelial-to-mesenchymal transition by protein kinase A and signal transducers and activators of transcription 3. Cancer Res 66, 8617–8624.
44. Yang Y, Pan X, Lei W, Wang J and Song J (2006) Transforming growth factor-beta1 induces epithelial-to-mesenchymal transition and apoptosis via a cell cycle-dependent mechanism. Oncogene 25, 7235–7244.
45. Miao ZF, Zhao TT, Wang ZN, Miao F, Xu YY, Mao XY, Gao J, Wu JH, Liu XY, You Y et al. (2014) Transforming growth factor-beta1 signaling blockade attenuates gastric cancer cell-induced peritoneal mesothelial cell fibrosis and alleviates peritoneal dissemination both in vitro and in vivo. Tumour Biol 35, 3575–3583.
46. Rynne-Vidal A, Au-Yeung CL, Jimenez-Heffernan JA, Perez-Lozano ML, Cremades-Jimeno L, Barcena C, Cristobal-Garcia I, Fernandez-Chacon C, Yeung TL, Mok SC et al. (2017) Mesothelial-to-mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer. J Pathol 242, 140–151.
47. Webber J, Steadman R, Mason MD, Tabi Z and Clayton A (2010) Cancer exosomes trigger fibroblast to myofibroblast differentiation. Cancer Res 70, 9621–9630.
48. Chowdhury R, Webber JP, Gurney M, Mason MD, Tabi Z and Clayton A (2015) Cancer exosomes trigger mesenchymal stem cell differentiation into pro-angiogenic and pro-invasive myofibroblasts. Oncotarget 6, 715–731.
49. Sun Y, Liu WZ, Liu T, Feng X, Yang N and Zhou HF (2015) Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. J Recept Signal Transduct Res 35, 600–604.
50. Kim SH, Yu MA, Ryu ES, Jang YH and Kang DH (2012) Indoxyl sulfate-induced epithelial-to-mesenchymal transition and apoptosis of renal tubular cells as novel mechanisms of progression of renal disease. Lab Invest 92, 488–498.
51. Kim YK, Kim HJ, Kwon CH, Kim JH, Woo JS, Jung JS and Kim JM (2005) Role of ERK activation in cisplatin-induced apoptosis in OK renal epithelial cells. J Appl Toxicol 25, 374–382.
52. Strippoli R, Benedicto I, Perez Lozano ML, Cerezo A, Lopez-Cabrera M and del Pozo MA (2008) Epithelial-to-mesenchymal transition of peritoneal mesothelial cells is regulated by an ERK/NF-kappaB/Snail1 pathway. Dis Model Mech 1, 264–274.